The 2026 midterm elections have rewritten the political anatomy of Washington. A record-breaking cohort of Democratic physicians and scientists captured seats across the country, flipping the House and delivering what organisers are calling a “Stem swing” — a visceral, voter-led rebuke to years of funding cuts, institutional chaos and the rise of the Make America Healthy Again movement. For the first time since 1969, when Medicare and Medicaid were signed into law, a Democratic doctor will sit in the United States Senate. Two of them, in fact.
A diagnosis at the ballot box
The message from voters was unambiguous. “Enough,” said Dr Richard Besser, president of the Robert Wood Johnson Foundation. “People across America are frustrated by the high cost of living, exhausted trying to make ends meet, and fed up with a ridiculously expensive and complicated healthcare system. They want leaders who understand how hard it is and will do something to make their lives better.”
That frustration found its voice in candidates like Dr Abdul El-Sayed in Michigan and Dr Annie Andrews in South Carolina. Their victories are not isolated. 3.14 Action, the political action committee dedicated to electing scientists and clinicians, is still counting wins across “hundreds” of state-level races — many too obscure to have reported final tallies. Erik Polyak, the group’s executive director, put it plainly: “2026 was a healthcare election. Healthcare affordability is the number one piece of that.”
The numbers bear him out. Democrats ran more than 158,000 healthcare-focused advertisements, according to the Cook Political Report, dwarfing the Republican effort by a margin of nearly three to one. 3.14 Action alone poured $23 million into independent expenditure ads, targeting everything from pharmaceutical price-gouging to insurance denials.
The collapse of the old guard
For a decade, the physician caucus in Congress has been overwhelmingly Republican and southern. Between 2011 and 2020, 86 per cent of doctor-legislators were Republicans; three-quarters hailed from southern states. This cycle, that dynamic inverted.
Representative Mariannette Miller-Meeks of Iowa, a stalwart ally of Health Secretary Robert F Kennedy Jr, lost her seat. Dr Roger Marshall, the Kansas senator and another Kennedy loyalist, was defeated. Three further Republican physicians remained locked in too-close-to-call races as of Thursday morning. Meanwhile, every incumbent Democratic doctor held their ground.
The contrast was stark. In Ohio, Dr Amy Acton — formerly the state’s health director during the darkest months of the Covid-19 pandemic — turned her crisis leadership into an electoral asset. In Iowa, Christina Bohannan, a law professor rather than a clinician, campaigned on a platform of restoring research funding as rising cancer rates became a bipartisan concern in the state.
Science under siege
The electoral revolt did not emerge from a vacuum. It was forged in the wreckage of a systematic dismantling of federal health infrastructure.
The Centers for Disease Control and Prevention has shed up to a third of its workforce — even as the nation confronts a record-breaking measles outbreak. The National Institutes of Health, the world’s largest public funder of biomedical research, has seen leadership gutted and path-breaking studies stalled, cancelled or censored. The Food and Drug Administration struggled to contain a historic cyclosporiasis outbreak, a parasitic illness causing severe diarrhoea, while short-staffed and under-resourced.
On election day itself, New York health authorities confirmed the state’s first paediatric measles death in thirty years. A child. Dead. From a disease eliminated in the United States in 2000.
Kennedy’s tenure has been defined by disruption. Vaccine programmes were defunded to appease a fervent base, even as four in ten “Maha voters” cited healthcare costs as their primary anxiety. The irony was not lost on organisers. “Kennedy was our number one recruitment and fundraising tool — hands down,” Polyak said before the polls opened.
The road ahead: governing amid the rubble
The new Democratic majority will be sworn into a crisis of their own making. The most draconian provisions of the Republican-led One Big Beautiful Bill Act take effect on New Year’s Day 2027. Medicaid work requirements — emblematic of the legislation’s punitive approach — are projected to strip coverage from 17 million Americans over the next decade.
They will face a phalanx of industry lobbyists. Insurers and pharmaceutical companies, accustomed to friendly ears, will deploy vast resources to shape — or stall — the Democratic agenda, which ranges from a public option to single-payer proposals. Public health organisations are already demanding Kennedy’s removal.
“In a lot of ways, this election represented the beginning of the end of RFK Jr’s disastrous leadership,” Polyak said. “It’s clear Americans want something different — they didn’t elect all these Democratic scientists just to oppose Trump. People want to see an alternative agenda. They want to see what Democratic scientists can deliver for them.”
Why it Matters
This election was not merely a partisan shift; it was a referendum on competence. Voters handed power to professionals who have spent careers navigating the gap between evidence and ideology, between a patient’s chart and a system’s cruelty. The new doctor-lawmakers inherit a public health architecture that has been deliberately hollowed out — and a populace that has watched, waited, and suffered. Their legitimacy rests not on slogans but on the trust earned at bedsides and lab benches. If they cannot translate that trust into legislation that lowers costs, restores capacity and protects the vulnerable, the “Stem swing” will be remembered as a fleeting spasm rather than a realignment. The patients are watching. The clock is ticking.